These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 5843526)

  • 21. Treatment of mild hypertension. Preliminary results of a two-year feasibility trial.
    Perry HM
    Circ Res; 1977 May; 40(5 Suppl 1):I180-7. PubMed ID: 576852
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of permanent arterial hypertension by a combination of reserpine and a salidiuretic].
    Cachin JC; Milliez P
    Sem Ther; 1967 Feb; 43(2):86-7. PubMed ID: 5600414
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of the effect of verapamil in hypertensive patients].
    Gelman A; de Albuquerque EM; Reynaldo Stella S; Draibe SA; Ajzen H
    Arq Bras Cardiol; 1983 Jan; 40(1):69-71. PubMed ID: 6351814
    [No Abstract]   [Full Text] [Related]  

  • 24. [Respective roles of hemodynamic or humoral factors and of hypotensive or salidiuretic drugs in the development of essential hypertension].
    Froment R; Froment A; Zech P
    Pathol Biol; 1965 Nov; 13(21):1094-102. PubMed ID: 4875799
    [No Abstract]   [Full Text] [Related]  

  • 25. [Decrease in neonatal mortality through treatment of essential hypertension in pregnant women].
    Blom van Assendelft PM; Dorhout Mees EJ; Hart PG
    Ned Tijdschr Geneeskd; 1968 Jun; 112(24):1115-8. PubMed ID: 5668480
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractory hypertension.
    Gillum RF
    J Natl Med Assoc; 1984 Nov; 76(11):1048. PubMed ID: 6502722
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypotensive diuretics and abnormalities of carbohydrate metabolism].
    Momose M; Takasawa A; Imamura B; Hasegawa M; Asano T
    Saishin Igaku; 1969 Jun; 24(6):1289-92. PubMed ID: 5805581
    [No Abstract]   [Full Text] [Related]  

  • 28. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    Baronchelli A; Agosta R; Verdecchia P; Bichisao E
    Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
    [No Abstract]   [Full Text] [Related]  

  • 29. [On combined therapy of hypertension and heart insufficiency. Advantages and disadvantages].
    Hueber EF
    Wien Klin Wochenschr; 1966 Oct; 78(40):657-60. PubMed ID: 5972532
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiac insufficiency appearing in essential arterial hypertension].
    Bartorelli C
    Bull Acad R Med Belg; 1972; 12(2):163-81. PubMed ID: 5074746
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of essential hypertension with quinethazone and reserpine].
    Diamond S; Feldman E
    Hospital (Rio J); 1965 Jul; 68(1):83-8. PubMed ID: 5322319
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diltiazem for treatment of essential hypertension: a double-blind controlled study with reserpine.
    Ogawa K; Ban M; Ito T; Watanabe T; Kobayashi T; Yamazaki N; Suzuki Y
    Clin Ther; 1984; 6(6):844-53. PubMed ID: 6391669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertension, saluretics and glucose tolerance].
    Jahnecke J
    Dtsch Med Wochenschr; 1967 Jun; 92(28):1270-8. PubMed ID: 6028137
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prazosin in moderate or severe essential arterial hypertension not controlled with chlorthalidone. A multicenter study].
    Saldanha RV; Macruz R; Santana PC; de Lima JJ; Zalc S; Pileggi F
    Arq Bras Cardiol; 1983 Jun; 40(6):433-8. PubMed ID: 6667153
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the antihypertensive efficacy of acebutolol, chlorthalidone and the combination of acebutolol and chlorthalidone in the treatment of mild and moderate primary arterial hypertension].
    Del Nero Júnior E; Lima EV; Savioli RM; de Rezende MC
    Arq Bras Cardiol; 1983 May; 40(5):357-61. PubMed ID: 6360100
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypotensive drugs. II. General considerations.
    Br Med J; 1969 May; 2(5654):430-2. PubMed ID: 5781490
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum cholesterol during treatment of hypertension with diuretic drugs.
    Ames RP; Peacock PB
    Arch Intern Med; 1984 Apr; 144(4):710-4. PubMed ID: 6712367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of the association of furosemide and reserpine in the treatment of arterial hypertension].
    Molaschi M; Bartoli E; Viara A; Puggioni G
    Minerva Med; 1970 Mar; 61(20):953-60. PubMed ID: 5434363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.